Aprea Therapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KAprea Therapeutics, Inc.APREAug 28

   Current report

2. ROUTINESCHEDULE 13G/AAprea Therapeutics, Inc.APREAug 13

   Ownership stake disclosure by Laurence W Lytton (amended)

   Laurence W Lytton, filed by

3. NOTABLE10-QAprea Therapeutics, Inc.APREAug 12

   Quarterly report

4. ROUTINE8-KAprea Therapeutics, Inc.APREAug 12

   Current report

5. ROUTINE8-KAprea Therapeutics, Inc.APREJul 23

   Current report

6. ROUTINE4Aprea Therapeutics, Inc.APREJun 17

   8 insider filings

   Michael Grissinger, insider filing for APRE

   Show all 8

   • 4Insider filing for APREJun 17
   • 4Insider filing for APREJun 17
   • 4Insider filing for APREJun 17
   • 4Insider filing for APREJun 17
   • 4Insider filing for APREJun 17
   • 4Insider filing for APREJun 17
   • 4Insider filing for APREJun 17
   • 4Insider filing for APREJun 17

   Michael Grissinger, reporting

7. ROUTINE8-KAprea Therapeutics, Inc.APREJun 17

   Current report

8. ROUTINESCHEDULE 13GAprea Therapeutics, Inc.APREMay 15

   Ownership stake disclosure by Vestal Point Capital, LP

   Vestal Point Capital, LP, filed by

9. ROUTINE424B7Aprea Therapeutics, Inc.APREMay 15

   Securities offering

10. NOTABLE10-QAprea Therapeutics, Inc.APREMay 13

    Quarterly report

11. ROUTINE8-KAprea Therapeutics, Inc.APREMay 13

    Current report

12. ROUTINEARSAprea Therapeutics, Inc.APREApr 30

    Annual report to shareholders

13. ROUTINEDEFA14AAprea Therapeutics, Inc.APREApr 30

    Additional proxy materials

14. ROUTINEDEF 14AAprea Therapeutics, Inc.APREApr 30

    Proxy statement

15. ROUTINEEFFECTAprea Therapeutics, Inc.APREApr 30

    Registration declared effective

16. ROUTINE424B3Aprea Therapeutics, Inc.APREApr 29

    Securities offering

17. ROUTINESCHEDULE 13G/AAprea Therapeutics, Inc.APREApr 27

    Ownership stake disclosure by Orin Hirschman (amended)

    Orin Hirschman, filed by

18. ROUTINES-3Aprea Therapeutics, Inc.APREApr 22

    Securities offering

19. ROUTINEPRE 14AAprea Therapeutics, Inc.APREApr 20

    Preliminary proxy statement

20. ROUTINESCHEDULE 13GAprea Therapeutics, Inc.APREApr 7

    Ownership stake disclosure by Squadron Capital Management LLC

    Squadron Capital Management LLC, filed by

21. ROUTINESCHEDULE 13GAprea Therapeutics, Inc.APREApr 1

    Ownership stake disclosure by Soleus Private Equity Fund III, L.P.

    Soleus Private Equity Fund III, L.P., filed by

22. ROUTINE4Aprea Therapeutics, Inc.APREApr 1

    2 insider filings

    John P. Hamill, insider filing for APRE

    Show all 2

    • 4Insider filing for APREApr 1
    • 4Insider filing for APREApr 1

    John P. Hamill, reporting

23. ROUTINE8-KAprea Therapeutics, Inc.APREApr 1

    Current report

24. ROUTINE8-KAprea Therapeutics, Inc.APREMar 30

    Current report

25. ROUTINEEFFECTAprea Therapeutics, Inc.APREMar 20

    Registration declared effective

26. ROUTINE424B3Aprea Therapeutics, Inc.APREMar 19

    Securities offering

27. ROUTINES-3/AAprea Therapeutics, Inc.APREMar 17

    Securities offering (amended)

28. ROUTINE4Aprea Therapeutics, Inc.APREMar 16

    2 insider filings

    Oren Gilad, insider filing for APRE

    Show all 2

    • 4Insider filing for APREMar 16
    • 4Insider filing for APREMar 16

    Oren Gilad, reporting

29. ROUTINES-8Aprea Therapeutics, Inc.APREMar 16

    Employee stock plan registration

30. NOTABLE10-KAprea Therapeutics, Inc.APREMar 16

    Annual report

31. ROUTINE8-KAprea Therapeutics, Inc.APREMar 16

    Current report

32. ROUTINES-3Aprea Therapeutics, Inc.APREFeb 20

    Securities offering

33. ROUTINE8-KAprea Therapeutics, Inc.APREFeb 18

    Current report

34. ROUTINESCHEDULE 13G/AAprea Therapeutics, Inc.APREFeb 13

    Ownership stake disclosure by Nantahala Capital Management, LLC (amended)

    Nantahala Capital Management, LLC, filed by

35. ROUTINE4Aprea Therapeutics, Inc.APREFeb 2

    2 insider filings

    Oren Gilad, insider filing for APRE

    Show all 2

    • 4Insider filing for APREFeb 2
    • 4Insider filing for APREFeb 2

    Oren Gilad, reporting

36. ROUTINE8-KAprea Therapeutics, Inc.APREJan 29

    Current report

37. ROUTINESCHEDULE 13G/AAprea Therapeutics, Inc.APREJan 28

    Ownership stake disclosure by Orin Hirschman (amended)

    Orin Hirschman, filed by

38. ROUTINE8-KAprea Therapeutics, Inc.APREJan 23

    Current report

39. ROUTINE8-KAprea Therapeutics, Inc.APREJan 9

    Current report

40. ROUTINEEFFECTAprea Therapeutics, Inc.APREDec 30, 2025

    Registration declared effective

Older filings on EDGAR